Abdullah R Ali, Age 7417 Fisher Island Ct, Monroe Twp, NJ 08831

Abdullah Ali Phones & Addresses

17 Fisher Island Ct, Monroe Twp, NJ 08831 (201) 656-3601

Monroe Township, NJ

Stonington, CT

Jersey City, NJ

21 Riverbend Dr, Mystic, CT 06355 (860) 536-7031

46 Riverbend Dr, Mystic, CT 06355 (860) 245-5852 (860) 536-7031 (682) 214-1305

Colleyville, TX

Fairfield, CT

Fairfield, TX

Show more

Mentions for Abdullah R Ali

Resumes & CV records

Resumes

Abdullah Ali Photo 50

Associate Research Scientist At Columbia University Medical Center

Position:
Associate Research Scientist at Columbia University Medical Center
Location:
New York, New York
Industry:
Hospital & Health Care
Work:
Columbia University Medical Center - New York since Jun 2013
Associate Research Scientist
Cincinnati Childrens Hospital Medical Center - Cincinnati May 2008 - May 2013
Research Associate
Cincinnati Childrens Hospital Medical Center - Cincinnati Area May 2005 - Apr 2008
Research Fellow
Indian Institute of Science - Bangalore, India. Jan 2005 - Apr 2005
Research Assistant
Indian Institute of Science - Bangalore, India. Aug 2000 - Dec 2004
Graduate Student
Education:
Indian Institute of Science 2000 - 2004
Ph.D., Genetics, Molecular Biology
Osmania University 1998 - 2000
M.Sc., Genetics
Osmania University 1995 - 1998
B.Sc., Microbiology, Zoology, Chemistry
Skills:
Molecular Biology, Cell Biology, recombinant DNA technology, Mutagenesis, Subcloning, Bacterial Culture, Agarose Gel Electrophoresis, Immunoprecipitation, Site-directed Mutagenesis, Affinity Chromatography, Media Preparation, Column Chromatography, Laboratory Techniques, Centrifugation, Autoclave, pH meter, Microscopes, Cytogenetics, Human Genetics, Epigenetics, Antibodies, Cell Culture, Transfection, Primer Design, Sequence Analysis, RNA isolation, DNA extraction, Genetics, Gene Regulation, FPLC, Immunofluorescence, Western Blotting, Word, Excel, PowerPoint, Photoshop, Adobe Acrobat, Microsoft Excel, Microsoft Word
Languages:
Hindi
English
Urdu
Arabic
Telugu
Awards:
Travel award
Fanconi Anemia Research Fund
Fanconi Anemia Research Fund Travel award to attend 22nd Annual Fanconi Anemia Research Fund Scientific Symposium, Minneapolis, Minnesota, USA.
Best Poster
Fanconi Anemia Research Fund
Best Translational Poster award at 19th Annual Fanconi Anemia Research Fund Scientific Symposium, Chicago, Illinois, USA.
Travel award
Department of Science and Technology, Government of India.
Department of Science and Technology, Government of India, Travel Award to attend 53rd Annual Meeting of the American Society of Human Genetics, Los Angeles, U.S.A.
Travel Award
Indian Institute of Science
Indian Institute of Science, Bangalore, India, Travel award to attend 53rd Annual Meeting of the American Society of Human Genetics, Los Angeles, U.S.A.
Senior Research Fellowship
Council of Scientific and Industrial Research, Government of India.
Council of Scientific and Industrial Research Senior Research Fellowship (SRF) to pursue doctoral research from August 2002 till the time Ph.D. degree awarded in December 2004. Award include monthly stipend, house rent allowance (HRA) and annual contingent grant.
Junior Research Fellowship
Council of Scientific and Industrial Research, Government of India.
Council of Scientific and Industrial Research Junior Research Fellowship to pursue doctoral research from August 2000 to July 2002. Award include monthly stipend, house rent allowance (HRA) and annual contingent grant.
National Eligibility Test
Council of Scientific and Industrial Research and the University Grants Commission, Government of India.
Qualified National Eligibility Test or NET, a national level entrance examination for postgraduate aspirants who seek to qualify in PhD research and also for the candidates who wish to pursue teaching jobs at Universities in India.
Merit Award Certificate and Scholarship
Commissioner of Collegiate Education, Government of Andhra Pradesh, India.
Uttama Vidyardhula Upakara Vethanam, also known as Merit Award Certificate and Scholarship from 1995 to 1998. This scholarship is given to meriterous students in the state for a period of three years, based on the merit list provided by the Board of Intermediate Education, Government of Andhra Pradesh.
Certifications:
Site-Specific Radiation Safety Training, University of Cincinnati
Abdullah Ali Photo 51

Shipping At Clarion

Position:
Shipping at Clarion
Location:
Other
Industry:
Logistics and Supply Chain
Work:
Clarion
Shipping
Education:
Oman
Abdullah Ali Photo 52

Owner, Duluk Petroleum

Position:
Owner at Duluk Petroleum
Location:
United States
Industry:
Oil & Energy
Work:
Duluk Petroleum
Owner
Abdullah Ali Photo 53

Abdullah Ali

Location:
United States
Abdullah Ali Photo 54

Abdullah Ali

Location:
United States
Abdullah Ali Photo 55

Abdullah Ali

Location:
United States
Abdullah Ali Photo 56

Abdullah Ali

Location:
United States
Abdullah Ali Photo 57

Eng At Mvp

Location:
United States
Industry:
Insurance

Publications & IP owners

Us Patents

Method For Precipitating Natural Avermectins

US Patent:
5905034, May 18, 1999
Filed:
Jul 10, 1997
Appl. No.:
8/891198
Inventors:
Abdullah R. Ali - Mystic CT
Assignee:
Pfizer Inc. - New York NY
International Classification:
C12N1/20
US Classification:
4352535
Abstract:
A process for separating a natural B avermectin from a natural avermectin containing fermentation broth by using an aqueous precipitation. The process comprises extracting natural avermectins from the fermentation broth with a water miscible solvent and adding sufficient water to precipitate the natural B avermetins. Preferably, the water miscible solvent is a C. sub. 1 -C. sub. 3 alcohol, acetone, or acetonitrile. In addition, an acid, base, salt or surfactant may be added to facilitate the precipitation. This invention provides an isolation technique that substitutes the use of an aqueous precipitation for nonaqueous solvent precipitations. The reduction in use of nonaqueous solvents provides economic, environmental and safety benefits.

Method For Precipitating Natural Advermectins

US Patent:
5686274, Nov 11, 1997
Filed:
Jan 16, 1996
Appl. No.:
8/569200
Inventors:
Abdullah R. Ali - Mystic CT
Assignee:
Pfizer Inc. - New York NY
International Classification:
C12P 1706
C12P 2104
A01N 4304
C07H 1708
US Classification:
435125
Abstract:
A process for separating a natural B avermectin from a natural avermectin containing fermentation broth by using an aqueous precipitation. The process comprises extracting natural avermectins from the fermentation broth with a water miscible solvent and adding sufficient water to precipitate the natural B avermectins. Preferably, the water miscible solvent is a C. sub. 1 -C. sub. 3 alcohol, acetone, or acetonitrile. In addition, an acid, base, salt or surfactant may be added to facilitate the precipitation. This invention provides an isolation technique that substitutes the use of an aqueous precipitation for nonaqueous solvent precipitations. The reduction in use of nonaqueous solvents provides economic, environmental and safety benefits.

Anti-Cd33 And Nkg2D Ligand Chimeras For Treatment Of Myeloid Malignancies

US Patent:
2021039, Dec 23, 2021
Filed:
Feb 23, 2021
Appl. No.:
17/182422
Inventors:
- New York NY, US
Abdullah Mahmood ALI - New York NY, US
International Classification:
A61K 35/17
C07K 14/735
C07K 14/705
Abstract:
Disclosed herein are compositions and methods relating to fusion proteins that target a lineage-specific cell-surface antigen for treating hematological malignancies.

Compositions And Methods For Inhibition Of Lineage Specific Antigens

US Patent:
2021026, Aug 26, 2021
Filed:
Apr 29, 2021
Appl. No.:
17/244136
Inventors:
- New York NY, US
Florence BOROT - New York NY, US
Abdullah Mahmood ALI - New York NY, US
International Classification:
A61K 35/28
C12N 9/22
C12N 15/113
C07K 14/705
Abstract:
Disclosed herein are methods of administering an agent targeting a lineage-specific cell-surface antigen, e.g., CD33, and a population of hematopoietic cells that are deficient in the lineage-specific cell-surface antigen, e.g., CD33 for immunotherapy of hematological malignancies. Cells comprising mutations in CD33 are also provided, as are gRNAs targeting CD33.

Compositions And Methods For Inhibition Of Lineage Specific Antigens

US Patent:
2021025, Aug 19, 2021
Filed:
Apr 29, 2021
Appl. No.:
17/243987
Inventors:
- New York NY, US
Florence Borot - New York NY, US
Abdullah Mahmood Ali - New York NY, US
International Classification:
A61K 35/28
C07K 16/30
C12N 5/0789
A61P 35/00
A61P 43/00
A61P 35/02
A61K 35/17
C07K 14/725
C07K 14/705
C07K 16/28
Abstract:
Disclosed herein are methods of administering an agent targeting a lineage-specific cell-surface antigen and a population of hematopoietic cells that are deficient in the lineage-specific cell-surface antigen for immunotherapy of hematological malignancies.

Compositions And Methods For Inhibition Of Lineage Specific Antigens

US Patent:
2020027, Sep 3, 2020
Filed:
May 19, 2020
Appl. No.:
16/877932
Inventors:
- New York NY, US
Florence Borot - New York NY, US
Abdullah Mahmood Ali - New York NY, US
International Classification:
A61K 35/28
C07K 14/725
C07K 14/705
C07K 16/28
C07K 16/30
C12N 5/0789
A61K 35/17
Abstract:
Disclosed herein are methods of administering an agent targeting a lineage-specific cell-surface antigen and a population of hematopoietic cells that are deficient in the lineage-specific cell-surface antigen for immunotherapy of hematological malignancies.

Cd33 Exon 2 Deficient Donor Stem Cells For Use With Cd33 Targeting Agents

US Patent:
2020026, Aug 20, 2020
Filed:
Aug 28, 2018
Appl. No.:
16/640086
Inventors:
- New York NY, US
Abdullah Mahmood ALI - New York NY, US
Florence BOROT - New York NY, US
International Classification:
C07K 14/705
C07K 16/28
C07K 16/30
A61P 35/00
Abstract:
Disclosed herein are compositions and methods relating to agents that target a lineage-specific cell-surface antigen and a population of hematopoietic cells that are deficient in the lineage-specific cell-surface antigen for immunotherapy of hematological malignancies.

Compositions And Methods For Inhibition Of Lineage Specific Antigens

US Patent:
2019032, Oct 24, 2019
Filed:
Jun 25, 2019
Appl. No.:
16/451934
Inventors:
- New York NY, US
Florence Borot - New York NY, US
Abdullah Mahmood Ali - New York NY, US
International Classification:
A61K 35/28
C07K 14/705
C07K 16/30
C07K 16/28
C12N 5/0789
C07K 14/725
A61K 35/17
Abstract:
Disclosed herein are methods of administering an agent targeting a lineage-specific cell-surface antigen and a population of hematopoietic cells that are deficient in the lineage-specific cell-surface antigen for immunotherapy of hematological malignancies.

Isbn (Books And Publications)

Cultural History Of India During The British Period

Author:
Abdullah Yusuf Ali
ISBN #:
0404147232

Roman Transliteration Of The Holy Qur'An With Full Arabic Text

Author:
Abdullah Yusuf Ali
ISBN #:
0836409892

The Meaning Of The Holy Qur'An

Author:
Abdullah Yusuf Ali
ISBN #:
0915957159

Mary And Jesus In The Qur'An

Author:
Abdullah Yusuf Ali
ISBN #:
0915957248

The Meaning Of The Holy Qur'An

Author:
Abdullah Yusuf Ali
ISBN #:
0915957590

The Meaning Of The Holy Quran

Author:
Abdullah Yusuf Ali
ISBN #:
0915957086

The Meaning Of The Holy Qur'An

Author:
Abdullah Yusuf Ali
ISBN #:
0915957116

The Meaning Of The Holy Quran

Author:
Abdullah Yusuf Ali
ISBN #:
0915957175

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.